BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 21.85
-0.05 (-0.23%)
At close: Jul 9, 2026
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 2.91 billion as of July 9, 2026. Its market cap has decreased by -33.23% in one year.
Market Cap
2.91B
Enterprise Value
1.94B
Revenue
8.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.85
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 2.91B, an increase of 64.58%. That is a compound annual growth rate of 13.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.91B | -26.66% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.33B |
| BioGend Therapeutics | 3.27B |
| Shine-On BioMedical | 3.23B |
| Energenesis Biomedical CO.,LTD. | 3.17B |
| Chunghwa Chemical Synthesis & Biotech | 3.05B |
| Apex Biotechnology | 2.99B |
| Intech Biopharm | 2.93B |